Merck & Co. Noncontrolling interest transactions and other increased by 58.8% to -$80.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 33.3%, from -$60.00M to -$80.00M. Over 2 years (FY 2021 to FY 2024), Noncontrolling interest transactions and other shows a downward trend with a 14.0% CAGR.
lin_noncontrolling_interest_transactions_and_other| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$97.00M | -$59.00M | -$33.00M | -$103.00M | -$104.00M | -$68.00M | -$81.00M | -$234.00M | -$10.00M | -$3.00M | -$78.00M | -$220.00M | -$32.00M | -$42.00M | -$60.00M | -$194.00M | -$80.00M |
| QoQ Change | — | +39.2% | +44.1% | -212.1% | -1.0% | +34.6% | -19.1% | -188.9% | +95.7% | +70.0% | <-999% | -182.1% | +85.5% | -31.3% | -42.9% | -223.3% | +58.8% |
| YoY Change | — | — | — | — | -7.2% | -106.1% | +21.4% | -125.0% | — | +95.6% | +3.7% | +6.0% | -220.0% | <-999% | +23.1% | +11.8% | -33.3% |